Journal article
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
Abstract
BACKGROUND: The benefits of reducing blood pressure on the risks of major cardiovascular disease are well established, but uncertainty remains about the comparative effects of different blood-pressure-lowering regimens. We aimed to estimate effects of strategies based on different drug classes (angiotensin-converting-enzyme [ACE] inhibitors, calcium antagonists, angiotensin-receptor blockers [ARBs], and diuretics or beta blockers) or those …
Authors
Turnbull F
Journal
The Lancet, Vol. 362, No. 9395, pp. 1527–1535
Publisher
Elsevier
Publication Date
11 2003
DOI
10.1016/s0140-6736(03)14739-3
ISSN
0140-6736
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Adrenergic beta-AntagonistsAgedAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsCalcium Channel BlockersCardiovascular DiseasesDiureticsFemaleHeart FailureHumansHypertensionMaleMiddle AgedPlacebosProspective StudiesRandomized Controlled Trials as TopicRisk AssessmentTreatment Outcome